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General decapping activators target
different subsets of inefficiently
translated mRNAs
Feng He†, Alper Celik†‡, Chan Wu, Allan Jacobson*
Department of Microbiology and Physiological Systems, University of
Massachusetts Medical School, Massachusetts, United States
Abstract The Dcp1-Dcp2 decapping enzyme and the decapping activators Pat1, Dhh1, and
Lsm1 regulate mRNA decapping, but their mechanistic integration is unknown. We analyzed the
gene expression consequences of deleting PAT1, LSM1, or DHH1, or the DCP2 C-terminal domain,
and found that: i) the Dcp2 C-terminal domain is an effector of both negative and positive
regulation; ii) rather than being global activators of decapping, Pat1, Lsm1, and Dhh1 directly
target specific subsets of yeast mRNAs and loss of the functions of each of these factors has
substantial indirect consequences for genome-wide mRNA expression; and iii) transcripts targeted
by Pat1, Lsm1, and Dhh1 exhibit only partial overlap, are generally translated inefficiently, and, as
expected, are targeted to decapping-dependent decay. Our results define the roles of Pat1, Lsm1,
and Dhh1 in decapping of general mRNAs and suggest that these factors may monitor mRNA
translation and target unique features of individual mRNAs.
DOI: https://doi.org/10.7554/eLife.34409.001
Introduction
Decapping usually commits an mRNA to complete degradation and plays an important role in
eukaryotic cytoplasmic mRNA turnover (Valkov et al., 2017; Grudzien-Nogalska and Kiledjian,
2017; Parker, 2012). Decapping is required for general 5’ to 3’ mRNA decay (Decker and Parker,
1993), nonsense-mediated mRNA decay (NMD) (He and Jacobson, 2001), AU-rich element-medi-
ated mRNA decay (Yamashita et al., 2005; Fenger-Grøn et al., 2005), microRNA-mediated gene
silencing (Behm-Ansmant et al., 2006), and transcript-specific degradation (Dong et al., 2007;
Badis et al., 2004). In yeast, mRNA decapping is carried out by a single enzyme comprised of a reg-
ulatory subunit (Dcp1) and a catalytic subunit (Dcp2). Dcp1 is a small EVH domain protein essential
for mRNA decapping in vivo (She et al., 2004; Beelman et al., 1996) and Dcp2 is a 970-amino acid
protein containing a highly conserved Nudix domain at its N-terminus and a large extension at its
C-terminus (Gaudon et al., 1999; Dunckley, 1999). The Dcp2 N-terminal domain is essential for the
catalysis of cap removal, but may also have additional regulatory activity, as this domain also con-
tains the binding site for Dcp1 (She et al., 2008; Deshmukh et al., 2008) and interacts with the acti-
vation motif of a short Edc1 peptide in vitro in the presence of Dcp1 (Mugridge et al., 2018;
Valkov et al., 2016). The decapping role of the Dcp2 C-terminal domain is largely unknown. How-
ever, our recent experiments reveal that this domain includes both negative and positive regulatory
elements that control both the substrate specificity and the activation of the decapping enzyme
(He and Jacobson, 2015a).
In addition to the Dcp1-Dcp2 decapping enzyme, mRNA decapping also requires the functions of
specific regulators commonly dubbed ‘decapping activators’ (Parker, 2012). A large number of
decapping activators have been identified in yeast and other organisms (Jonas and Izaurralde,
2013; Parker, 2012), and these factors appear to target distinct classes of mRNA substrates. Pat1,
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Dhh1, and the Lsm1-7 complex are required for decapping of general wild-type mRNAs
(Parker, 2012), and NMD-specific regulators (Upf1, Upf2, and Upf3) are required for decapping of
nonsense-containing mRNAs (He and Jacobson, 2015b; Nicholson and Mu¨hlemann, 2010). Edc3
manifests the most fastidious substrate specificity, being required for decapping of only the yeast
YRA1 pre-mRNA and RPS28B mRNA (He et al., 2014; Dong et al., 2007; Badis et al., 2004). Two
additional factors, Edc1 and Edc2, originally isolated as high-copy suppressors of specific mutations
in DCP1 and DCP2, by themselves appear to be not required for mRNA decapping in vivo but can
enhance mRNA decapping in vitro (Borja et al., 2011; Dunckley et al., 2001). All of these decapp-
ing activators are conserved from yeast to humans, but their precise functions in mRNA decapping
regulation are largely unknown. The two major functions proposed for yeast decapping activators,
translational repression and decapping enzyme activation (Parker, 2012; Nissan et al., 2010;
Coller and Parker, 2005), are still controversial (Sweet et al., 2012; Arribere et al., 2011).
Yeast decapping activators exhibit highly specific interactions with each other and with the
decapping enzyme. Pat1 interacts with both Dhh1 and the Lsm1-7 complex (He and Jacobson,
2015a; Sharif et al., 2013; Sharif and Conti, 2013; Nissan et al., 2010; Bouveret et al., 2000;
Wu et al., 2014), Upf1, Upf2, and Upf3 interact with each other (He et al., 1997), and Edc3 interacts
with Dhh1 (He and Jacobson, 2015a; Sharif et al., 2013). Pat1, Upf1, and Edc3 also interact with
specific binding motifs in the large C-terminal domain of Dcp2 (He and Jacobson, 2015a;
Harigaya et al., 2010). These interaction data and additional observations led us to propose a new
model for regulation of mRNA decapping (He and Jacobson, 2015a) in which different decapping
activators form distinct decapping complexes in vivo, each of which has a unique substrate specificity
that targets a subset of yeast mRNAs. To test aspects of this model, and to further understand the
roles of Pat1, Dhh1, and the Lsm1-7 complex in general mRNA decapping we have analyzed the
effects of deletions of the PAT1, LSM1, or DHH1 genes and the large Dcp2 C-terminal domain on
transcriptome-wide mRNA accumulation. Our results reveal a critical role for the Dcp2 C-terminal
domain in regulating mRNA decapping, demonstrate that Pat1, Lsm1, and Dhh1 control the decapp-
ing of specific subsets of yeast mRNAs, and uncover substantial indirect consequences of mutations
in genes encoding components of the decapping apparatus.
Results
Elimination of the large Dcp2 C-terminal domain causes significant
changes in genome-wide mRNA expression
We previously identified multiple regulatory elements in the large C-terminal domain of Dcp2,
including one negative element that inhibits in vivo decapping activity and a set of positive elements
that promote both substrate specificity and decapping activation. The latter appear to operate by
binding to specific decapping activators such as Upf1, Edc3, and Pat1 (He and Jacobson, 2015a).
To extend our previous study and to further assess the roles of these Dcp2 regulatory elements in in
vivo decapping control, we analyzed the effect of C-terminal truncation of Dcp2 on transcriptome-
wide mRNA accumulation. RNA-Seq was used to analyze transcript populations in wild-type yeast
cells and in cells harboring the previously characterized dcp2-N245 allele (He and Jacobson,
2015a). This allele produces a Dcp2 decapping enzyme that contains only the first 245 amino acids
of the protein, and appears to have constitutively activated and indiscriminate decapping activity, at
least with respect to the limited number of mRNAs analyzed previously (He and Jacobson, 2015a).
As with any mutation, truncation of Dcp2 could have a direct effect on mRNA decapping, or it could
have an indirect effect on overall gene expression. To identify those transcripts directly affected by
C-terminal truncation of Dcp2, we constructed two additional isogenic strains with severely compro-
mised decapping activity and included these two strains in our RNA-Seq experiments. These strains,
dubbed dcp2-E153Q-N245 and dcp2-E198Q-N245, harbor the same dcp2-N245 allele but each also
contains one additional function-inactivating mutation in an active site residue of the Dcp2 Nudix
domain, that is glutamate (E) to glutamine (Q) substitutions at codon positions 153 and 198, respec-
tively. E153 of Dcp2 has been shown to function as a general base during the hydrolysis reaction
and E198 is involved in Mg2+ coordination within the Nudix domain (Aglietti et al., 2013). E153Q
and E198Q mutations essentially eliminate the decapping activity of Dcp2 both in vitro and in vivo
(Aglietti et al., 2013; He and Jacobson, 2015a).
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RNA-Seq libraries prepared from wild-type cells and from the isogenic strains harboring the
dcp2-N245, dcp2-E153Q-N245, or dcp2-E198Q-N245 alleles showed good read count distribution
(Figure 1A) and notable consistency between biological replicates, with Pearson correlation coeffi-
cients ranging from 0.96 to 0.99 (Figure 1 and Figure 1—figure supplement 1). Utilizing previously
described data analysis pipelines for transcript quantitation and assessment of differential expression
(Celik et al., 2017), we identified the transcripts that were differentially expressed in each of the
mutant strains relative to the wild-type strain. The decapping-deficient dcp2-E153Q-N245 and dcp2-
E198Q-N245 strains exhibited significant numbers of transcripts that were differentially expressed.
We identified 1921 up-regulated and 1845 down-regulated transcripts in the dcp2-E153Q-N245
strain, and 1346 up-regulated and 1428 down-regulated transcripts in the dcp2-E198Q-N245 strain
(Figure 1B,C,D). Given the general requirement for the decapping enzyme in yeast mRNA decay
(Parker, 2012), the detection of a large number of up-regulated transcripts in these two strains was
not surprising, that is the up-regulated transcripts are most likely bona fide substrates of the yeast
decapping enzyme. In support of this interpretation, the up-regulated transcript lists from these
strains contain all our previously characterized individual decapping substrates and also exhibited
highly significant overlap with the up-regulated transcript lists from dcp1D, dcp2D, xrn1D, and upf1/
2/3D cells (Figure 1—figure supplement 2). In contrast, the finding that a large number of tran-
scripts was also down-regulated in the two decapping-inactive strains was surprising. Similar obser-
vations were also made in our recent RNA-Seq analyses of dcp1D and dcp2D cells (Celik et al.,
2017). These results indicate that general inhibition of mRNA decapping may also have severe sec-
ondary effects on transcriptome-wide mRNA accumulation.
Examination of the up- and down-regulated transcript lists from the two catalytically inactive
strains revealed a significant overlap, but also notable differences (Figure 1B,C). The two strains
share 1186 up-regulated and 1362 down-regulated transcripts. However, the dcp2-E153Q-N245
strain yielded 575 more up-regulated and 417 more down-regulated transcripts than the dcp2-
E198Q-N245 strain. To explore whether there was a significant difference in the expression patterns
between these two strains, we applied the same differential expression pipeline but compared the
dcp2-E153Q-N245 and dcp2-E198Q-N245 libraries directly. This analysis revealed only 21 differen-
tially expressed transcripts between these two strains (Figure 1E, leftmost panel). From this result,
we conclude that there is no fundamental difference in expression patterns between the two strains.
However, because the two strains harbor different dcp2 alleles, the encoded decapping enzymes
may have slightly different albeit significantly reduced activities. Thus, some subtle differences in lev-
els of expression may actually exist for a large number of transcripts between the two strains, as we
noticed in our validation experiments (see below). The subtle differences in levels of expression for
these transcripts were likely captured in the dcp2-E153Q-N245 vs. WT but not in the dcp2-E198Q-
N245 vs. WT comparison.
Elimination of the entire C-terminal domain of Dcp2 significantly altered genome-wide mRNA
expression. Compared to WT cells, a total of 1530 transcripts were differentially expressed in dcp2-
N245 cells: 616 transcripts showed up-regulation and 914 transcripts showed down-regulation
(Figure 1B,C). To assess the specific effect of the C-terminal truncation of Dcp2 on mRNA decapp-
ing, we compared the expression pattern of the dcp2-N245 strain to the patterns of the dcp2-
E153Q-N245 and dcp2-E198Q-N245 strains (Figure 1B,C). Transcripts differentially expressed in
these three strains shared a partial overlap, but also exhibited notable differences. A significant frac-
tion of transcripts differentially expressed in the dcp2-N245 strain (324 out of 616 for the up-regu-
lated, and 650 out 914 for the down-regulated) had concordant up- or down-regulation in the
catalytically inactive strains. Interestingly, the majority of transcripts differentially expressed in the
catalytically inactive strains (1567 out of 1891 for the up-regulated, and 1261 out of 1911 for the
down-regulated) had unchanged levels in the dcp2-N245 strain. Furthermore, a significant fraction
of transcripts differentially expressed in the dcp2-N245 strain (292 out 616 for the up-regulated, and
264 out of 914 for the down-regulated) had unchanged levels in the catalytically inactive strains.
Together, these results indicate that the dcp2-N245 strain and the two catalytically inactive strains
have largely different global mRNA expression patterns and suggest that the C-terminal truncation
of Dcp2 does not block general mRNA decapping, but causes deregulation of decapping for specific
mRNAs. To further support this conclusion, we carried direct pairwise comparisons between the
dcp2-N245 and the dcp2-E153Q-N245 or dcp2-E198Q-N245 libraries. The dcp2-N245 strain yielded
1658 up-regulated and 1690 down-regulated transcripts compared to the dcp2-E153Q-N245 strain,
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Figure 1. Identification of transcripts differentially expressed in dcp2-N245, dcp2-E153Q-N245, and dcp2-E198Q-N245 cells. (A) Violin and box plots
displaying the average and median read count distributions of the RNA-Seq libraries from WT, dcp2-N245, dcp2-E153Q-N245, and dcp2-E198Q-N245
strains in three independent experiments. (B) Venn diagram displaying the relationships between transcripts up-regulated in dcp2-N245, dcp2-E153Q-
N245, and dcp2-E198Q-N245 cells. (C) Venn diagram displaying the relationships between transcripts down-regulated in dcp2-N245, dcp2-E153Q-
Figure 1 continued on next page
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and 1113 up-regulated 1090 down-regulated compared to the dcp2-E198Q-N245 strain (Figure 1E,
middle and right panels), further illustrating these differences. The distinct mRNA expression pat-
terns observed in dcp2-N245, dcp2-E153Q-N245, and dcp2-E198Q-N245 cells most likely originated
from different Dcp2 decapping activities, as the levels of the Dcp2 proteins expressed in these cells
were similar or nearly identical (Figure 1—figure supplement 4).
Elimination of the C-terminal domain of Dcp2 deregulates but does not
block mRNA decapping
Our comparison of the transcripts differentially expressed between dcp2-N245 cells and cells
expressing the two decapping-deficient alleles suggested that the dcp2-N245 truncation causes
deregulated decapping but not decapping inhibition. To explore this concept further, we examined
correlations of the transcriptome-wide profiles of all transcripts in the dcp2-N245 strain and in yeast
strains severely comprised in decapping activity (dcp2-E153Q-N245 or dcp2-E198Q-N245 cells) or
strains lacking decapping or 5’ to 3’ exoribonuclease activities (dcp1D, dcp2D, and xrn1D cells). As
controls, we also did pairwise comparisons of the profiles for the latter group of strains. In this analy-
sis, profiling data for the dcp1D, dcp2D, and xrn1D strains were from our recently published study
(Celik et al., 2017). Because the dcp1D, dcp2D, and xrn1D libraries were prepared at a different
time, to improve the consistency, we used the relative levels (i.e., the fold changes relative to the
corresponding WT control) of each transcript in all these strains in our analyses. As shown in
Figure 2A, the dcp1D and dcp2D strains, or the dcp2-E153Q-N245 and dcp2-E198Q-N245 strains,
showed excellent correlation (Pearson correlation coefficients = 0.868 and 0.932, respectively). The
dcp1D and dcp2D strains also showed good correlation with the dcp2-E153Q-N245, dcp2-E198Q-
N245 or xrn1D strains (Pearson correlation coefficients = 0.812, 0.805, 0.748 for dcp1D and 0.772,
0.789, 0.734 for dcp2D strains, respectively). In contrast, the dcp2-N245 strain exhibited only modest
correlation with each of the dcp1D, dcp2D, dcp2-E153Q-N245, dcp2-E198Q-N245, or xrn1D strains
(Pearson correlation coefficients = 0.371, 0.345, 0.423, 0.421, and 0.379). These results indicate that
the dcp2-N245 strain has a significantly different expression profile from yeast strains severely defi-
cient in or lacking decapping or 5’ to 3’ exoribonuclease activities, further arguing that the C-termi-
nal truncation of Dcp2 deregulates but does not block mRNA decapping.
To validate our RNA-Seq results and to assess the potential mechanisms of decapping deregula-
tion caused by elimination of the Dcp2 C-terminal domain, we focused on a group of 264 transcripts
that were down-regulated uniquely in dcp2-N245 cells (Figure 1C). Because the levels of transcripts
from this group were not altered in dcp2-E153Q-N245 or dcp2-E198Q-N245 cells, we reasoned that
Figure 1 continued
N245, and dcp2-E198Q-N245 cells. (D) Scatterplots comparing the normalized read counts between the WT and the dcp2-N245, dcp2-E153Q-N245, or
dcp2-E198Q-N245 strains for transcripts differentially expressed in each of the mutant strains. Left panel, comparison for the 616 up- and 1025 down-
regulated transcripts in dcp2-N245 cells; middle panel, comparison for the 1921 up- and 1845 down-regulated transcripts in dcp2-E153Q-N245 cells;
and right panel, comparison for the 1346 up- and 1428 down-regulated transcripts in dcp2-E198Q-N245. (E) Scatterplots comparing the normalized
read counts for transcripts differentially expressed between the dcp2-E153Q-N245 and dcp2-E198Q-N245 strains, or in these two strains compared to
the dcp-N245 strain. Left panel, comparison for 21 differentially expressed transcripts between dcp2-E153Q-N245 and dcp2-E198Q-N245 cells; middle
panel, comparison for the 1658 up- and 1690 down-regulated transcripts in dcp2-E153Q-N245 cells; and right panel, comparison for the 1113 up- and
1090 down-regulated transcripts in dcp2-E198Q-N245 cells. The log2 read count values of individual transcripts were used in the analyses of parts D
and E, and the y = x line is shown in red.
DOI: https://doi.org/10.7554/eLife.34409.002
The following figure supplements are available for figure 1:
Figure supplement 1. RNA-Seq libraries generated from WT, dcp2-N245, dcp2-E153Q-N245, and dcp2-E198Q-N245 strains exhibit good correlation
between three different biological replicates.
DOI: https://doi.org/10.7554/eLife.34409.003
Figure supplement 2. Yeast transcripts stabilized by inactivating the catalytic function of Dcp2 are mostly decapping substrates.
DOI: https://doi.org/10.7554/eLife.34409.004
Figure supplement 3. Yeast transcripts destabilized by deletion of the large Dcp2 C-terminal domain are not normally typical decapping substrates.
DOI: https://doi.org/10.7554/eLife.34409.005
Figure supplement 4. Western blotting analysis of protein levels in cells with different dcp2 alleles.
DOI: https://doi.org/10.7554/eLife.34409.006
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their decreased accumulation in dcp2-N245 cells was likely to be caused by accelerated or indiscrim-
inate decapping by a constitutively activated Dcp2 decapping enzyme which had lost its negative
regulation. To test this hypothesis, we examined whether elimination of XRN1, a gene encoding the
5’ to 3’ exoribonuclease that functions downstream of decapping, can restore the levels of the
down-regulated transcripts in dcp2-N245 cells. To assess the specificity of XRN1 deletion, we also
analyzed the effects of elimination of SKI2 or SKI7 on the accumulation of the down-regulated tran-
scripts in dcp2-N245 cells. SKI2 encodes a 3’ to 5’ RNA helicase, SKI7 encodes a GTPase, and both
gene products are required for exosome-mediated 3’ to 5’ mRNA decay (Parker, 2012). We con-
structed a set of yeast double mutant strains harboring the dcp2-N245 allele and deletions of the
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Figure 2. Elimination of the Dcp2 C-terminal domain deregulates mRNA decapping in vivo. (A) Yeast cells harboring a deletion of the large Dcp2
C-terminal domain exhibit a significantly different genome-wide expression pattern from cells severely comprised in decapping activity or completely
lacking decapping or 5’ to 3’ exoribonuclease activities. Scatterplot matrices were used to compare the relative levels of all transcripts in the yeast
transcriptome in different mutant strains. The relative levels of individual mRNAs in each of the mutant strains were determined by comparisons to the
appropriate wild-type strain. Data for the dcp1D, dcp2D, and xrn1D strains were from our previous study (Celik et al., 2017). Log2 transformed data
were used for this analysis and Pearson correlation coefficients for each comparison are shown in red. (B) Yeast cells harboring a deletion of the large
Dcp2 C-terminal domain exhibit accelerated and indiscriminate decapping of mRNAs. Eleven representative transcripts (nine typical decapping
substrates and two atypical decapping substrates) from the group of transcripts down-regulated uniquely in dcp2-N245 cells were selected and their
levels of expression in the indicated strains were analyzed by northern blotting. In each case, a specific random-primed probe was hybridized to the
blot and the SCR1 transcript served as a loading control. The relative levels of specific transcripts in the mutant strains were determined by
comparisons to their levels in the wild-type strain (indicated by the values under each blot). For presentation purposes, one of the control SCR1 blots is
duplicated and is indicated by the lower case letter ‘a.’ The SER3 locus produces two different transcripts and only the levels of the short isoform
(indicated by #) are presented.
DOI: https://doi.org/10.7554/eLife.34409.007
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XRN1, SKI2, or SKI7 genes. As additional controls, we also constructed yeast double mutants harbor-
ing the dcp2-E153Q-N245 or dcp2-E198Q-N245 alleles and a deletion of XRN1. We selected eleven
representative transcripts from the down-regulated group and employed northern blotting to ana-
lyze the decay phenotypes of these transcripts in the respective single and double mutant strains.
Among the eleven selected transcripts, nine (GDH1, ARL1, DAL3, YGL117W, RPS9A, SUC2, CPA1,
HIS4, and SER3) are typical decapping substrates and two (HCA1 pre-mRNA and HSP82 mRNA) are
atypical decapping substrates, that is the latter are normally subject to degradation by other decay
pathways. As shown in Figure 2B, all eleven transcripts manifested decreased levels in dcp2-N245
cells compared to wild-type cells. Deletion of XRN1 completely restored the mRNA levels in dcp2-
N245 cells for almost all transcripts. In contrast, elimination of SKI2 or SKI7 had no effect on mRNA
levels for each of the eleven transcripts in dcp2-N245 cells. These results validate our RNA-Seq anal-
yses and demonstrate that decreased accumulation of these representative transcripts in dcp2-N245
cells is indeed caused by accelerated or opportunistic decapping of the mRNAs. This experiment
provides direct experimental evidence that Dcp2 is subject to negative regulation through its C-ter-
minal domain and that loss of this negative regulation causes indiscriminate mRNA decapping.
Decapping activators Pat1, Lsm1, and Dhh1 target specific subsets of
yeast transcripts with overlapping substrate specificity
To assess the roles of the general decapping activators Pat1, Lsm1, and Dhh1 in mRNA decay, we
generated yeast strains harboring single deletions of the PAT1, LSM1, or DHH1 genes and analyzed
the expression profiles of the resulting pat1D, lsm1D, and dhh1D strains by RNA-Seq. The RNA-Seq
libraries from these strains showed good read count distribution (Figure 3A) and notable consis-
tency between biological replicates (Figure 3—figure supplement 1). Using the same analysis pipe-
line described above, we identified 940 up-regulated and 685 down-regulated transcripts in pat1D
cells, 955 up-regulated and 681 down-regulated transcripts in lsm1D cells, and 1098 up-regulated
and 788 down-regulated transcripts in dhh1D cells (Figure 3B–D). Because the functions of Pat1,
Lsm1, and Dhh1 are required for general mRNA decapping (Coller and Parker, 2005; Fischer and
Weis, 2002; Coller et al., 2001; Tharun et al., 2000; Bouveret et al., 2000), detection of a large
number of up-regulated transcripts in pat1D, lsm1D, and dhh1D cells was expected. The up-regu-
lated transcripts are likely the bona fide substrates of these decapping activators, but detection of
comparable numbers of down-regulated transcripts in each of these strains was largely unexpected.
Much like our observations of the strains with catalytically-deficient Dcp2, deletion of the PAT1,
LSM1, or DHH1 genes may have secondary effects on genome-wide mRNA expression.
To explore the functional relationships of Pat1, Lsm1, and Dhh1 in mRNA decay, we compared
the up- and down-regulated transcript lists from the pat1D, lsm1D, and dhh1D strains. As shown in
Figure 3B and C, transcripts differentially expressed in the pat1D and lsm1D strains exhibited highly
significant overlap. About 84% of the up-regulated transcripts (864 out of 1031) and 77% of the
down-regulated transcripts (583 out of 756) were shared by these two strains. Transcripts differen-
tially expressed in the dhh1D strain exhibited partial overlap with those in the pat1D and lsm1D
strains. About 50% of the up-regulated transcripts (542 out of 1098) and 43% of the down-regulated
transcripts (342 out of 788) in the dhh1D strain were shared by the pat1D or lsm1D strains. In addi-
tion, 482 transcripts were commonly up-regulated and 290 commonly down-regulated in all three
strains. Given the substantial overlap of differentially expressed transcripts in the pat1D and lsm1D
strains, and the physical interactions between Pat1 and the Lsm1-7 complex (Wu et al., 2014;
Bouveret et al., 2000), we tested whether Pat1 and Lsm1 controlled the expression of the same set
of transcripts. Utilizing the same differential expression analysis pipeline, we compared the
pat1D and lsm1D libraries directly. The pat1D and lsm1D strains manifested remarkable consistency
in their expression profiles over the entire transcriptome, with only four transcripts differentially
expressed between the two strains, two of which were caused by the respective gene deletions
(Figure 3E, leftmost panel, red dots). Direct comparisons were also applied to the dhh1D and pat1D
or lsm1D libraries. This analysis revealed significant differences in the expression profiles between
the dhh1D and pat1D or lsm1D strains (Figure 3E, last two panels). The dhh1D strain yielded 1332
up-regulated and 874 down-regulated transcripts compared to the pat1D strain, and 1385 up-regu-
lated and 1037 down-regulated transcripts compared to the lsm1D strain.
Together, these results indicate that Pat1, Lsm1, and Dhh1 target specific subsets of yeast tran-
scripts with overlapping substrate specificity. Pat1 and Lsm1 appear to function together and target
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Figure 3. Identification of transcripts controlled by Pat1, Lsm1, and Dhh1. (A) Violin and box plots displaying the average and median read count
distributions of the RNA-Seq libraries from the WT, pat1D, lsm1D, and dhh1D strains in three independent experiments. (B) Venn diagram displaying the
relationships between transcripts up-regulated in pat1D, lsm1D, and dhh1D cells. (C) Venn diagram displaying the relationships between transcripts
down-regulated in pat1D, lsm1D, and dhh1D cells. (D) Scatterplots comparing the normalized read counts between the WT and the pat1D, lsm1D, or
Figure 3 continued on next page
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the same set of transcripts in yeast cells. Dhh1 appears to have distinct functions from Pat1 and
Lsm1 and targets a set of transcripts that only partially overlaps with those regulated by Pat1 and
Lsm1. Because Pat1 interacts with both Lsm1 and Dhh1 (Bouveret et al., 2000; Sharif and Conti,
2013; Sharif et al., 2013) we sought to ascertain that the observed overlapping substrate specific-
ities for Pat1, Lsm1, and Dhh1 originated from specific activating functions of these factors, and not
from the secondary effects of co-depletion of their interacting partners. Accordingly, we analyzed
the levels of Pat1, Lsm1, and Dhh1 in specific gene deletion backgrounds by employing genomic
TAP-tagged PAT1, LSM1, or DHH1 alleles known to be functional (Bouveret et al., 2000;
Fischer and Weis, 2002). We found that deletion of PAT1 had little or no effect on the levels of
expression of Lsm1 and Dhh1 (Figure 3—figure supplement 2B and C). Similarly, deletion of DHH1
also had no significant effect on the levels of expression of Pat1 and Lsm1 (Figure 3—figure supple-
ment 2A and B). Deletion of LSM1 had no effect on the level expression of Dhh1 (Figure 3—figure
supplement 2C), but consistent with a previous observation (Bonnerot et al., 2000), decreased the
level of expression of Pat1 to 35% of its level in wild-type cells (Figure 3—figure supplement 2A).
The decreased accumulation of Pat1 in the absence of Lsm1 does not contradict our overall interpre-
tation of overlapping mRNA expression patterns between pat1D and lsm1D cells, and, in fact, this
observation strengthens our conclusion that Pat1 and Lsm1 function together to promote mRNA
decapping. Collectively, these results indicate that the observed overlapping substrate specificities
of Pat1, Lsm1, and Dhh1 are attributable to their specific activating functions in mRNA decapping.
Identification of transcripts uniquely and commonly targeted by Pat1,
Lsm1, and Dhh1
Based on the well established in vivo functions and in vitro activities of Pat1, Lsm1, and Dhh1
(Nissan et al., 2010; Coller and Parker, 2005; Fischer and Weis, 2002; Coller et al., 2001;
Tharun et al., 2000; Bouveret et al., 2000), we considered the up-regulated transcripts in the
pat1D, lsm1D and dhh1D strains to be direct substrates of these decapping activators for the most
part, and the respective down-regulated transcripts in these strains to arise indirectly as a conse-
quence of general defects in mRNA decapping (see above). To evaluate the reliability of these prop-
ositions, we examined the expression patterns of these up- and down-regulated transcripts in
dcp1D, dcp2D, and xrn1D cells as well as in dcp2-N245, dcp2E-153Q-N245, and dcp2E-198Q-N245
cells. Further, to gain insight into the overlapping vs. distinct regulatory activities of Pat1, Lsm1, and
Dhh1, we divided the differentially expressed transcripts from pat1D, lsm1D, and dhh1D cells into six
distinct subgroups based on their decay phenotypes and examined the distribution of the relative
levels of transcripts from these subgroups in each of the mutant strains. The up-regulated transcripts
were divided into three non-overlapping subgroups: Up-o-d, up-regulated only in the dhh1D strain
(556 transcripts); Up-o-pl, up-regulated only in the pat1D and lsm1D strains (382 transcripts); and
Up-a-pld, up-regulated in all three deletion strains (482 transcripts) (Figure 3B). Similarly, the down-
regulated transcripts were also divided into three non-overlapping subgroups: Down-o-d, down-
Figure 3 continued
dhh1D strains for transcripts differentially expressed in each of the mutant strains. Left panel, comparison for the 955 up- and 681 down-regulated
transcripts in pat1D cells; middle panel, comparison for the 940 up- and 685 down-regulated transcripts in lsm1D cells; and right panel, comparison for
the 1098 up- and 788 down-regulated transcripts in dhh1D cells. (E) Scatterplots comparing the normalized read counts between the pat1D and lsm1D
strains for all transcripts, or between the dhh1D strain and the lsm1D and pat1D strains for transcripts differentially expressed in these two strains
compared to the dhh1D strain. Left panel, comparison for all transcripts between the pat1D and lsm1D strains, four differentially expressed transcripts
are indicated by red dots; middle panel, comparison for the 1385 up- and 1037 down-regulated transcripts in the lsm1D strain with respect to the
transcripts of the dhh1D strain; and right panel, comparison for the 1332 up- and 874 down-regulated transcripts in the pat1D strain with respect to the
transcripts of the dhh1D strain. For A to E, all analyses were as described in the legend to Figure 1.
DOI: https://doi.org/10.7554/eLife.34409.008
The following figure supplements are available for figure 3:
Figure supplement 1. RNA-Seq libraries generated from WT, pat1D, lsm1D, and dhh1D strains exhibit good correlation between three different
biological replicates.
DOI: https://doi.org/10.7554/eLife.34409.009
Figure supplement 2. Western blotting analysis of Pat1, Lsm1, and Dhh1 levels in different mutant strains.
DOI: https://doi.org/10.7554/eLife.34409.010
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regulated only in the dhh1D strain (446 transcripts); Down-o-pl, down-regulated only in the pat1D
and lsm1D strains (293 transcripts); and Down-a-pld, down-regulated in all three deletion strains (290
transcripts) (Figure 3C).
Transcripts from the six subgroups had distinct expression patterns in dcp1D, dcp2D, xrn1D,
dcp2-N245, dcp2-E153Q-N245, and dcp2-E198Q-N245 cells (Figure 4A–F). Transcripts from two of
the up-regulated subgroups, Up-o-d and Up-a-pld, exhibited similar expression patterns and had
significantly increased levels of expression (relative to the WT strain) in all six mutant strains. Tran-
scripts from the third up-regulated subgroup, Up-o-pl, exhibited a slightly different expression pat-
tern and had significantly increased levels in dcp1D, dcp2D, dcp2-E153Q-N245, and dcp2-E198Q-
N245 cells, marginally increased levels in xrn1D cells, but unaltered levels in dcp2-N245 cells. These
results show that transcripts from the three up-regulated subgroups are all sensitive to the loss of
decapping activity, indicating that they are bona fide substrates of the decapping enzyme and the
general 5’ to 3’ decay pathway. The marginal effect of XRN1 deletion on the expression of the tran-
scripts from the Up-o-pl subgroup suggests that, once decapped, a significant fraction of transcripts
from this subgroup can also be efficiently degraded by the 3’ to 5’ decay pathway. This possibility is
consistent with experiments demonstrating that deletion of SKI2 can partially restore the levels of
mRNAs downregulated in cells harboring deletions of PAT1 or LSM1. Figure 4—figure supplement
1 shows that deletion of SKI2 partially increased the levels of the GTT2 and RPP1A mRNAs in pat1D
and lsm1D cells, but did not increase the levels of these two mRNAs in dhh1D cells.
Transcripts from the three down-regulated subgroups exhibited two different expression pat-
terns. Transcripts from the Down-o-d and Down-a-pld subgroups had significantly decreased levels
in all six mutant strains. This result shows that transcripts from these two subgroups are sensitive to
both partial and complete loss of decapping activity as well as to complete loss of the 5’ to 3’ exori-
bonuclease activity. The concordant down-regulation observed for these transcripts in all our mRNA
decay mutant strains strongly argues that they are indirectly controlled by the general 5’ to 3’ decay
activities. Transcripts from the down-regulated Down-o-pl subgroup had significantly decreased lev-
els in dcp1D, dcp2D, dcp2-E153Q-N245, and dcp2-E198Q-N245 cells but increased levels in xrn1D
and dcp2-N245 cells. The increased expression of these transcripts in response to deletion of XRN1
and C-terminal truncation of Dcp2 suggests that they are also bona fide substrates of the decapping
enzyme and thus are likely controlled by Pat1 and Lsm1 directly. Based on our observations in ski2D
cells lacking Pat1 or Lsm1 (see above), the decreased levels of transcripts in dcp1D, dcp2D, dcp2-
E153Q-N245, and dcp2-E198Q-N245 cells suggests that when decapping is completely blocked,
these transcripts may also be more efficiently degraded by the 3’ to 5’ decay pathway.
Collectively, these results indicate that transcripts from all three up-regulated subgroups and one
of the down-regulated subgroups (Down-o-pl) are substrates of the decapping enzyme and thus are
likely to be direct targets of Pat1, Lsm1, and Dhh1. In contrast, transcripts from the other two down-
regulated subgroups (Down-o-d and Down-a-pld) appear to be controlled indirectly by the general
5’ to 3’ decay activities and thus are not the direct targets of Pat1, Lsm1, and Dhh1. To obtain fur-
ther support for this conclusion, we analyzed the pattern of the codon protection index for tran-
scripts in each of these six subgroups. This index is a measure of the degree of a transcript’s co-
translational 5’ to 3’ decay and is defined as the ratio of sequencing reads in the ribosome protected
frame over the average reads of the non-protected frames of the 5’ to 3’ decay intermediates from a
specific transcript (Pelechano et al., 2015). Values greater than one are indicators of co-translational
5’ to 3’ decay. As shown in Figure 4G, transcripts from the Up-o-d, Up-o-pl, Up-a-pld, and Down-o-
pl subgroups all had median codon protection index values greater than 1. In contrast, transcripts
from the Down-o-d and Down-a-pld subgroups both had median codon protection index values less
than 1. These data strengthen our conclusion on the separation of differentially expressed transcripts
into direct target and non-target categories. Based on their expression patterns, we suggest that
transcripts from the Up-o-d subgroup are targeted by Dhh1, transcripts from the Up-o-pl and Down-
o-pl subgroups are targeted by Pat1 and Lsm1, and transcripts from the Up-a-pld subgroup are tar-
geted by all three factors.
Validation of transcripts controlled directly or indirectly by Pat1, Lsm1,
and Dhh1
To validate the results from our RNA-Seq analyses and to assess the proposed decay mechanisms
for transcripts in different subgroups controlled by Pat1, Lsm1, and Dhh1, we selected 34 transcripts
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Figure 4. Transcripts from different subgroups of mRNAs regulated by Pat1, Lsm1, or Dhh1 have distinct expression patterns in cells deficient in
decapping or 5’ to 3’ exoribonuclease activities and also exhibit distinct extents of co-translational mRNA decay. Transcripts up-regulated in pat1D,
lsm1D, or dhh1D strains were divided into three non-overlapping Up-o-d, Up-o-pl, and Up-a-pld subgroups, representing transcripts up-regulated only
in dhh1D cells, only in pat1D and lsm1D cells, and in all three deletion strains, respectively. Similarly, transcripts down-regulated in the three deletion
strains were also divided into three non-overlapping Down-o-d, Down-o-pl, and Down-a-pld subgroups, representing transcripts down-regulated only
in dhh1D cells, only in pat1D and lsm1D cells, and in all three deletion strains, respectively. Transcripts not regulated by Pat1, Lsm1, or Dhh1 were put
into the none subgroup. Boxplots were used to depict the distributions of both the relative expression levels and the codon protection indices for
transcripts in each of these subgroups. In these analyses, the relative expression levels of individual mRNAs in each of the mutant strains were
determined by comparisons to the corresponding wild-type strain. The codon protection index of individual mRNAs was based on 5’P seq experiments
of wild-type cells under normal growth conditions (Pelechano et al., 2015). Log2 transformed data were used to generate all plots except for panel G,
and the color codes for the boxplots include: blue for the up-regulated subgroups, red for the down-regulated subgroups, and green for transcripts
not regulated by Pat1, Lsm1, or Dhh1. A to F. Boxplots showing the distributions of the relative expression levels for different subgroups in dcp1D (A),
dcp2D (B), xrn1D (C), dcp2-N245 (D), dcp2-E153Q-N245 (E), and dcp2-E198Q-N245 (F) cells. (G) Boxplots showing the distributions of the codon
protection indices for different subgroups.
DOI: https://doi.org/10.7554/eLife.34409.011
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(representing mRNAs from each subgroup) and analyzed both their levels and patterns of expression
by northern blotting. In this experiment, we analyzed mRNA levels in wild-type, pat1D, lsm1D, and
dhh1D strains, but also included dcp1D, dcp2D, xrn1D, dcp2-N245, dcp2-E153Q-N245, and dcp2-
E198Q-N245 strains to assess each transcript’s sensitivity to 5’ to 3’ decay, and upf1D, edc3D,
scd6D, ski2D, ski7D, and ski2Dski7D strains to serve as negative controls. Our northern analyses con-
firmed the expression patterns for 30 out of 34 selected transcripts. As shown in Figure 5, four tran-
scripts (CIT2, SDS23, HOS2, and PYK2) from the Up-o-d subgroup all had increased levels only in
dhh1D cells but not in pat1D and lsm1D cells; four transcripts (DIF1, AGA1, BUR6, and LSM3) from
the Up-o-pl subgroup all had increased levels only in pat1D and lsm1D cells but not in dhh1D cells;
ten transcripts (HXT6, GPH1, HXK1, CHA1, RTC3, NQM1, PGM2, TMA10, GAD1, and SPG4) from
the Up-a-pld subgroup all had increased levels in pat1D, lsm1D, and dhh1D cells; and two transcripts
(MUP3 and GTT2) from the Down-o-pl subgroup both had decreased levels in pat1D and lsm1D cells,
but not in dhh1D cells. Importantly, the twenty transcripts from these four subgroups all had
increased levels in dcp1D, dcp2D, dcp2-E153Q-N245, and dcp2-E198Q-N245 cells, and nineteen out
twenty transcripts (except GTT2) also had increased levels in xrn1D cells. These results support our
proposition that transcripts from these four subgroups are all bona fide substrates of the decapping
enzyme and provide direct evidence that these transcripts are indeed degraded by the general 5’ to
3’ decay pathway. Also as expected, three transcripts (RPP1A, TMA19, and GPD2) from the Down-a-
pld subgroup all had decreased levels in pat1D, lsm1D, and dhh1D cells. Consistent with the idea
that these transcripts were affected indirectly as a consequence of a general defect in decapping, all
three transcripts also had decreased levels in in dcp1D, dcp2D, dcp2-E153Q-N245, and dcp2-
E198Q-N245 cells. Interestingly, these three transcripts only had slightly increased levels in xrn1D
cells, suggesting they, too, may be mostly degraded by the 3’ to 5’ decay pathway. Five transcripts
(YIL164C, THI22, EST1, TRP1-1, and ALR2) from the Down-o-d subgroup had decreased levels only
in dhh1D cells but not in pat1D and lsm1D cells (Figure 8D, see below).
The four transcripts that could not be confirmed deviated from expectations for different reasons:
one had an extremely low expression level and could not be effectively verified (SFG1), one had
complex isoforms that are not annotated in the genome releases (FRE3), and therefore not used in
our statistical procedures, and the other two (ASC1 pre-mRNA and mRNA) were most likely bioinfor-
matics false positives due to multiple alignment artifacts of sequence reads to the spliced and
unspliced isoforms from the same locus.
To ascertain that the increased steady-state levels of the transcripts from the Up-o-d, Up-o-pl,
and Up-a-pld subgroups in the respective deletion cells result from changes in mRNA decay rates,
we constructed a set of yeast rpb1-1 strains containing deletions of PAT1, LSM1, or DHH1 and
determined half-lives for fourteen transcripts that had been validated by northern blotting (above).
As shown in Figure 6A and B, two representative transcripts (SDS23 and PYK2) from the Up-o-d
subgroup both had increased half-lives in dhh1D cells, that is from 8.0 and 12.6 min respectively in
wild-type cells to 21.0 min in each case in dhh1D cells. Similarly, compared to wild-type cells, three
representative transcripts (DIF1, BUR6, and LSM3) from the Up-o-pl subgroup all had increased half-
lives in pat1D and lsm1D cells. Finally, three representative transcripts (CHA, HXT6, GPH1, and
HXK1) from the Up-a-pld subgroup all had increased half-lives in pat1D, lsm1D, and dhh1D cells. We
also analyzed the decay rates for six additional transcripts (GPH1, RTC3, NQM1, PGM2, TMA10,
and GAD1) from the Up-a-pld subgroup, but were unable to generate reliable half-lives for these
transcripts. These six transcripts are all encoded by annotated stress responsive genes and their
transcription could not be inhibited by either thermal inactivation of rpb1-1 or by treating cells with
thiolutin (data not shown). These results indicate that the increased steady-state accumulation of
transcripts from the three subgroups in pat1D, lsm1D, and dhh1D cells are most likely direct conse-
quences of the loss of Pat1, Lsm1, and Dhh1 functions in mRNA decapping and suggest that at least
Figure 4 continued
The following figure supplement is available for figure 4:
Figure supplement 1. Inhibition of the 3’ to 5’ mRNA decay pathway partially restores the levels of transcripts down-regulated in pat1D and lsm1D
cells, but not in dhh1D cells.
DOI: https://doi.org/10.7554/eLife.34409.012
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a significant fraction of transcripts from these three subgroups are direct targets of Pat1, Lsm1, and
Dhh1. In addition, our observation that Pat1, Lsm1, and Dhh1 function in repressing the expression
of transcripts from stress responsive genes suggests that the regulatory activities of these three fac-
tors may also play an important role in cellular responses to environmental stresses.
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Figure 5. Validation of representative transcripts regulated by Pat1, Lsm1, or Dhh1. Representative transcripts from five of the subgroups (Up-o-d, Up-
o-pl, Up-a-pld, Down-o-pl, and Down-a-pld) described in Figure 4 were selected and their steady-state levels in the indicated strains were analyzed.
Since individual blots were reprobed multiple times for different transcripts some SCR1 blots served as controls for different transcripts. The shared
SCR1 blots are indicated by lower case letters a, b, c, d, e, and f, respectively.
DOI: https://doi.org/10.7554/eLife.34409.013
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Transcripts targeted by Pat1, Lsm1, and Dhh1 are all translated
inefficiently
Given the intimate linkage of mRNA translation and decay (Mishima and Tomari, 2016;
Presnyak et al., 2015; Roy and Jacobson, 2013), and to gain insight into the roles of Pat1, Lsm1,
and Dhh1 in decapping regulation, we sought to identify any unique properties associated with the
translation of transcripts controlled by these three factors. To this end, we analyzed the pattern and
distribution of the average codon optimality score, the average ribosome density, and the estimated
protein abundance for transcripts from the six subgroups of differentially expressed mRNAs in
pat1D, lsm1D, and dhh1D cells. In this analysis, the average codon optimality score of individual tran-
scripts was based on the scores defined by Pechmann and Frydman (Pechmann and Frydman,
2013) and these scores are in fact the normalized tRNA adaptation index in which mRNA abundan-
ces are used to correct for the number of codons vs. number of tRNA genes. Ribosomal densities
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Figure 6. Decay rates of representative transcripts regulated by Pat1, Lsm1, or Dhh1. Representative transcripts from the upregulated subgroups
described in Figure 4 (Up-o-d, Up-o-pl, and Up-a-pld) were selected and their decay rates were determined by northern blot quantitation of the
fraction of mRNA remaining after a temperature-shift in rpb1-1, rpb1-1/pat1D, rpb1-1/lsm1D, and rpb1-1/dhh1D cells. The quantitative data (% of mRNA
remaining) at different time points after the temperature shift relative to time point zero for each transcript shown in panel A is plotted in panel B. For
each graph in panel B, the Y-axis represents the percentage of mRNA remaining and the X-axis represents time in minutes. In each case, the data were
fitted to a single exponential equation and the slope (k) and the squared regression co-efficiency (r2) of the regression line were determined. Half-lives
of each transcript in different strains were calculated using the formula T1/2=ln2/k. Data from the first five time points were used for graphing SDS23,
PYK2, DIF1, BUR6, and CHA1 mRNA decay rates. However, data from the last four and last three time points were used for graphing HXT6 and HXK1
mRNA decay rates, respectively, as the latter two mRNAs exhibited delayed transcriptional inhibition during the temperature shift. As noted in the
legend to Figure 5, individual blots were reprobed for different transcripts. The shared SCR1 blots are indicated by lower case letters g and h.
DOI: https://doi.org/10.7554/eLife.34409.014
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were derived from published ribosome profiling and RNA-Seq data from wild-type yeast cells grown
under standard conditions (Young et al., 2015). Protein abundance levels were obtained from the
curated PaxDb (Protein Abundances Across Organisms) database (Wang et al., 2012) and comprise
the scaled aggregated estimates over several proteomic data sets.
As shown in Figure 7A–C, transcripts from the three up-regulated Up-o-d, Up-o-pl, and Up-a-pld
subgroups exhibited similar and consistent data patterns: they all had relatively low average codon
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Figure 7. Transcripts from different subgroups of mRNAs regulated by Pat1, Lsm1, and Dhh1 have distinct
translational properties. Boxplots were used to examine the distributions of average codon optimality scores,
ribosome occupancies, and scaled protein abundances for transcripts from each of the six regulation subgroups
described in Figure 4. In this analysis, codon optimality scores are based on the normalized tRNA adaptation
index (Pechmann and Frydman, 2013), ribosome occupancies are based on ribosome footprint profiling data of
wild-type cells under normal growth conditions (Young et al., 2015), and protein abundance scores are based on
curated data in a database (Wang et al., 2015; Wang et al., 2012). A to C. Boxplots showing the distributions of
scaled average codon optimality scores (A) and Log2 transformed data of ribosome occupancies (B) or scaled
protein abundances (C). Boxplots are color coded as described in the legend to Figure 4.
DOI: https://doi.org/10.7554/eLife.34409.015
He et al. eLife 2018;7:e34409. DOI: https://doi.org/10.7554/eLife.34409 15 of 30
Research article Chromosomes and Gene Expression
optimality scores, high ribosome densities, and low protein levels. These observations indicate that
transcripts from these three subgroups are all translated inefficiently, most likely because of less effi-
cient translation elongation. Transcripts from the three down-regulated subgroups exhibited two dif-
ferent data patterns. Transcripts from the Down-o-d and Down-a-pld subgroups exhibited one
consistent data pattern: they all had relatively high average codon optimality scores, low ribosome
densities, and high protein levels. These observations suggest that transcripts from these two sub-
groups are translated efficiently, a characteristic probably reflecting highly efficient translation elon-
gation. Transcripts from the Down-o-pl subgroup had a distinct data pattern: they had relatively low
average codon optimality scores and low ribosome densities, but relatively high protein levels. These
observations suggest that transcripts from this subgroup may be inefficiently translated, but have
relatively long mRNA half-lives. Together, these results indicate that transcripts targeted directly by
Pat1, Lsm1, and Dhh1 are all translated less efficiently. In contrast, transcripts controlled indirectly
by these three factors appear to be translated more efficiently.
Notably, although the Dhh1 function in mRNA decay was recently suggested to be linked to
codon optimality (Radhakrishnan et al., 2016), our analyses revealed that the average codon opti-
mality score of individual transcripts was not a reliable predictor of the Dhh1 requirement for their
decay. Transcripts targeted by Dhh1 (from the Up-o-d and Up-a-pld subgroups) had a low but broad
range of average codon optimality scores (Figure 7A). Interestingly, in that range, there were also
thousands of transcripts that were not targeted by Dhh1, including transcripts uniquely targeted by
Pat1 and Lsm1 (from the Up-o-pl and Down-o-pl subgroups), as well as transcripts targeted by none
of these three factors. This raises the possibility that additional decay factors may be responsible for
targeting these transcripts.
Pat1, Lsm1, and Dhh1 have non-overlapping functions with NMD
factors in mRNA decapping regulation
To further define the roles of Pat1, Lsm1, and Dhh1 in mRNA decapping regulation, we examined
the functional relationships between these three factors and the NMD factors Upf1, Upf2, and Upf3.
We compared the transcripts targeted by Pat1, Lsm1, and Dhh1 to those targeted by the three Upfs
(Celik et al., 2017). As shown in Figure 8A, transcripts from the Up-o-d, Up-o-pl, and Up-a-pld sub-
groups all had only minimal and insignificant overlap with NMD substrates. In addition, as revealed
by a two-dimensional hierarchical clustering analysis of differentially expressed transcripts, pat1D,
lsm1D, and dhh1D cells also had profiles distinct from those of upf1D, upf2D, and upf3D cells
(Figure 8B). These results indicate that the general decapping activators Pat1, Lsm1, and Dhh1 have
roles that are distinct from and non-overlapping with those of the NMD factors in mRNA decapping
regulation.
Deletion of DHH1 promotes the degradation of a fraction of NMD
substrates
We recently demonstrated that yeast decapping activators form distinct complexes with the decapp-
ing enzyme in vivo (He and Jacobson, 2015a), suggesting that different decapping activators may
compete with each other for binding to the decapping enzyme. One implication of this notion is that
in addition to providing targeting specificity for the decapping enzyme, decapping activators can
also control each other’s activities indirectly by limiting or promoting the free pool of available
decapping enzyme. A testable prediction of this dynamic mRNA decapping regulation is that, in
addition to stabilizing its targeted transcripts, deletion of a specific activator may also promote the
degradation of substrates of the alternative mRNA decay pathways. To test this hypothesis, we
examined whether the down-regulated subgroups from the differentially expressed transcripts in
pat1D, lsm1D, and dhh1D cells may contain NMD substrates. This analysis revealed that the three
subgroups exhibited significantly different enrichment patterns for NMD substrates (Figure 8C). The
Down-o-d subgroup (transcripts down-regulated only in dhh1D cells) was enriched for NMD sub-
strates (Fisher’s exact test, p = 7.3  10 15). In contrast, the Down-o-pl (transcripts down-regulated
only in in pat1D and lsm1D cells) was depleted of NMD substrates (Fisher’s exact test,
p = 6.2  10 6). Finally, the Down-a-pld subgroup (transcripts down-regulated in all three deletion
strains) showed neither enrichment for nor depletion of NMD substrates (Fisher’s exact test
p = 0.12). These results provide additional evidence that transcripts from the Down-o-pl subgroup
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Figure 8. Decapping activators have distinct targeting specificities and display dynamic regulation. (A) Venn diagram depicting minimal significant
overlaps between transcripts targeted by the Upf factors and those targeted by Dhh1 or Pat1 and Lsm1. (B) Two-dimensional clustering analysis of
differentially expressed transcripts showing distinct expression patterns of yeast cells harboring deletions of the UPF1, UPF2, UPF3, PAT1, LSM1, or
DHH1 genes. The relative levels of individual mRNAs in the deletion strains were determined by comparisons to the corresponding wild-type strain.
Figure 8 continued on next page
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are direct targets of Pat1 and Lsm1, and show that the Down-o-d subgroup contains a fraction of
NMD-targeted transcripts. To validate the latter observation, we selected five representative NMD
substrates that were also down-regulated in dhh1D cells and analyzed their expression levels and
patterns in a set of yeast strains described above. As expected, northern analyses showed that all
five transcripts (YIL164C, THI22, EST1, TRP1-1, and ALR2) had decreased levels in dhh1D cells but
increased levels in upf1D, dcp1D, dcp2D, and xrn1D cells (Figure 8D, left panel). The decreased
accumulation for these five transcripts in dhh1D cells largely resulted from degradation by NMD as
elimination of UPF1 from dhh1D cells caused substantial increases (ranging from 4.0- to 21.6-fold) in
the expression levels of each of these five transcripts (Figure 8D, right panel). Interestingly, we also
observed that dhh1D upf1D cells consistently accumulated lower levels (ranging from 28% to 81%)
than upf1D cells for each of these five transcripts (Figure 8D, right panel), suggesting that deletion
of DHH1 can also promote NMD-independent degradation of these transcripts. Together, these
results indicate that deletion of DHH1 can promote the degradation of a subset of NMD substrates
by both NMD-dependent and NMD-independent mechanisms, thus arguing that decapping activa-
tors can indeed exert indirect control of each other’s activities in mRNA decapping. This may indi-
cate that the decapping enzyme is limiting under normal growth conditions.
Discussion
Dcp2 C-terminal domain imparts critical in vivo regulatory activities in
mRNA decapping
The yeast Dcp2 decapping enzyme subunit has a modular structure encompassing a conserved 245-
amino acid N-terminal Nudix catalytic domain and a 725-amino acid C-terminal extension. While the
catalytic function of the N-terminal domain in cap removal is well established (Floor et al., 2010;
She et al., 2008; Deshmukh et al., 2008; She et al., 2006), the decapping role of the large Dcp2
C-terminal domain remains to be clarified. Here, we provide genetic evidence that the Dcp2 C-ter-
minal domain imparts important regulatory activities to the decapping enzyme, thus playing a critical
role in regulating mRNA decapping in vivo. Elimination of the C-terminal domain altered the expres-
sion of more than a quarter of yeast’s protein-coding genes and led to both up- and down-regula-
tion of specific transcripts (Figure 1B,C). A key observation supporting a predominantly regulatory
role for the C-terminal domain is that transcripts differentially expressed in cells lacking the Dcp2
C-terminal domain only exhibited limited correlation with those differentially expressed in cells
whose decapping activity was either severely comprised or essentially absent (Figure 2A).
Our recent experiments revealed that the Dcp2 C-terminal domain harbors both negative and
positive regulatory elements (He and Jacobson, 2015a), leading us to propose that the decapping
enzyme is subject to both negative and positive regulation. Recent biochemical data also supports
this model (Paquette et al., 2018). Our expression profiling of yeast cells lacking the Dcp2 C-termi-
nal domain provides direct experimental evidence for both aspects of this hypothesis. Negative reg-
ulation of the decapping enzyme is supported by the observations that deletion of the Dcp2
C-terminal domain led to decreases in the abundance of hundreds of specific transcripts, and that
this down-regulation was dependent on maintenance of Dcp2’s catalytic activity (Figures 1C and
2B). Importantly, the vast majority of these down-regulated transcripts were not normal decapping
substrates (Figure 1—figure supplement 3). These results indicate that deletion of the Dcp2 C-ter-
minal domain eliminates an inhibitory function of the domain and leads to uncontrolled and acceler-
ated mRNA decapping by a constitutively activated and opportunistic Dcp2. Evidence for positive
Figure 8 continued
Log2 transformed ratios were used for clustering analyses. The data for the NMD factors were from our previous study (Celik et al., 2017). Color
coding used to represent fold change in expression employs red to indicate increases in levels and blue to indicate decreases in levels, with
intermediate changes scaled to lighter versions of each color. (C) Venn diagrams depicting the enrichment of NMD-targeted transcripts in the Down-
o-d subgroup, but not in the Down-a-pld and Down-o-pl subgroups of mRNAs indirectly controlled by Pat1, Lsm1, and Dhh1. (D) Northen blotting
analysis of representative transcripts from the Down-o-d subgroup of mRNAs that are targeted by NMD. Five transcripts were selected, and northern
blotting and transcript quantification were as described in the legend to Figure 2B.
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regulation of the decapping enzyme is provided by the observation that elimination of the Dcp2
C-terminal domain also caused up-regulation of hundreds of specific transcripts. As this group of
transcripts also exhibited concordant up-regulation in decapping-deficient cells (Figure 1B), it is
likely that the observed up-regulation originates from a deficiency in mRNA decapping caused by
loss of a positive regulatory function. Collectively, these observations indicate that the C-terminal
domain of Dcp2 encodes important regulatory activities and that loss of these regulatory activities
can have direct consequences on decapping of hundreds of specific mRNAs.
Over the past decade mechanistic investigations of mRNA decapping regulation have largely
been focused on the 245-amino acid N-terminal domain of Dcp2, with essentially all biochemical and
structural studies using this C-terminally truncated fragment (Mugridge et al., 2016; Borja et al.,
2011; Floor et al., 2010; She et al., 2008; Deshmukh et al., 2008; She et al., 2006; Wurm et al.,
2017; Wurm et al., 2016; Charenton et al., 2016; Mugridge et al., 2018). This Dcp2 fragment
binds to Dcp1, but lacks the binding sites for most decapping activators, including Pat1, Edc3, and
Upf1 (He and Jacobson, 2015a). Our genetic experiments here reveal that this N-terminal fragment
of Dcp2 encodes a constitutively active decapping enzyme in vivo that can target a variety of mRNAs
including those that normally use or do not use decapping-dependent mechanisms in their degrada-
tion (Figure 1B–C). Accordingly, current models of mRNA decapping regulation based on the Dcp2
N-terminal domain may be informative with respect to the catalytic step of decapping, but most
likely do not reflect complex aspects of mRNA decapping regulation in vivo such as substrate selec-
tion and decapping enzyme activation.
Pat1, Lsm1, and Dhh1 target subsets of yeast transcripts with
overlapping substrate specificity
Pat1, Lsm1, and Dhh1 have long been considered as general mRNA decapping activators and their
functions are usually thought to be required for decapping of most wild-type mRNAs (Parker, 2012;
Coller and Parker, 2004; Fischer and Weis, 2002; Coller et al., 2001; Bouveret et al., 2000;
Tharun and Parker, 1999). Contrary to this expectation, our expression profiling experiments
revealed that Pat1, Lsm1, and Dhh1 are only required for decapping of a subset of transcripts in
yeast cells and suggested that these factors have highly specific functions in controlling mRNA
decapping (Figure 3B). Consistent with strong in vivo physical interaction and shared in vitro RNA
binding properties (Wu et al., 2014; Sharif and Conti, 2013; Bouveret et al., 2000;
Chowdhury et al., 2007), our results indicate that Pat1 and Lsm1 function together (probably as a
Pat1-Lsm1-7 complex) to target the same set of transcripts (Figure 3B–E). Dhh1 targets a different
set of transcripts that only partially overlaps with those targeted by both Pat1 and Lsm1 (Figure 3B).
The partial overlap between transcripts commonly targeted by Pat1 and Lsm1 and those targeted
by Dhh1 strongly indicates that these three decapping activators have distinct functions in mRNA
decapping regulation and that decapping of individual mRNAs likely has different functional require-
ments for Pat1, Lsm1, and Dhh1. For example, we identified transcripts regulated by Dhh1 but not
by Pat1 and Lsm1 (the Up-o-d subgroup), transcripts regulated by Pat1 and Lsm1 but not by Dhh1
(the Up-o-pl and Down-o-pl subgroups), and transcripts regulated by all three factors (the Up-a-pld
subgroup). Since the degradation of transcripts controlled by Pat1, Lsm1, and Dhh1 individually or in
combination is dependent on the Dcp1-Dcp2 decapping enzyme and the Xrn1 5’ to 3’ exoribonu-
clease (Figures 4 and 5) the transcripts in these three groups are most likely bona fide decapping
substrates. Accordingly, our observation that decapping of individual mRNAs can have different
requirements for Pat1, Lsm1, and Dhh1 suggests that mRNA decapping is a multi-step process and
that Pat1, Lsm1, and Dhh1 are likely to function at different steps of the decapping pathway. Given
the genetic and physical interactions between Dhh1 and the Not1-Ccr4 deadenylase complex
(Chen et al., 2014; Rouya et al., 2014; Maillet and Collart, 2002; Hata et al., 1998; Ozgur et al.,
2015; Mathys et al., 2014), and the physical interaction between Pat1 and Dcp2 (Charenton et al.,
2017; He and Jacobson, 2015a), one possibility is that Dhh1 promotes deadenylation and that Pat1
and Lsm1 recruit the decapping enzyme. In addition, since Pat1 and Lsm1, but not Dhh1, also inter-
act with Xrn1 (Charenton et al., 2017), the former two factors may also control a step after decapp-
ing, that is 5’ to 3’ exonucleolytic digestion.
Transcripts targeted by Pat1, Lsm1, and Dhh1 all appear to be translated inefficiently as they
have relatively low average codon optimality scores, high ribosomal occupancy, and low protein pro-
duction (Figure 7). These observations indicate that the functions of Pat1, Lsm1, and Dhh1 in
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regulating decapping are probably linked to mRNA translation, a conclusion consistent with a recent
study linking Dhh1 function in mRNA decay to translation elongation through codon optimality
(Radhakrishnan et al., 2016). However, our results indicate that average codon optimality scores of
individual mRNAs do not correlate well with a Dhh1 requirement for their decay (Figure 7). Hence,
the identity and distribution of non-optimal codons in an mRNA may influence the targeting specific-
ity by Pat1, Lsm1, and Dhh1.
Over past two decades models for the general functions of Pat1, Lsm1, and Dhh1 in yeast mRNA
decapping were largely generated by assessing the fate of the transcripts derived from two key
reporter gene constructs (Fischer and Weis, 2002; Coller et al., 2001; Hatfield et al., 1996;
Decker and Parker, 1993). One reporter codes for the unstable MFA2 mRNA and the other codes
for the stable PGK1 mRNA. Both of these transcripts are in the datasets presented here and our
results show that the MFA2 mRNA is regulated by Pat1 and Lsm1, but not by Dhh1, and that the
PGK1 mRNA is not regulated by any of the three factors. These observations highlight potential
drawbacks to the use of reporter gene assays and lead to uncertainty about existing models. Most
importantly, since both reporter mRNAs are not regulated by Dhh1 it becomes difficult to justify
models in which Dhh1 has a direct role in decapping of these transcripts (Coller and Parker, 2005;
Fischer and Weis, 2002; Coller et al., 2001).
Pat1, Lsm1, and Dhh1 also have indirect roles in controlling genome-
wide mRNA expression
Our expression profiling experiments revealed that, in addition to targeting specific mRNAs for
decapping, Pat1, Lsm1, and Dhh1 also have indirect roles in controlling mRNA expression in yeast
and that eliminating the functions of any of these three factors can have severe consequences for
global mRNA accumulation. Unexpectedly, we found that deletions of PAT1, LSM1, and DHH1 also
resulted in down-regulation of hundreds of specific transcripts (Figure 3C). In contrast to the up-reg-
ulated transcripts, the vast majority of the down-regulated transcripts are not direct targets of Pat1,
Lsm1, or Dhh1 and their down-regulation is thus likely to result from an indirect consequence of los-
ing the primary functions of these factors in mRNA decapping. Two subgroups of transcripts that
are indirectly controlled by the activities of Pat1, Lsm1, and Dhh1 were identified. One subgroup
(Down-o-d) includes transcripts that were down-regulated only in dhh1D cells and the other sub-
group (Down-a-pld) includes transcripts that were down-regulated in all three deletion strains. The
transcripts from these two subgroups exhibited concordant down-regulation in yeast cells partially
compromised in, or completely lacking, decapping activity (Figure 4A–F). Collectively, these obser-
vations indicate that transcripts from the Down-o-d and Down-a-pld subgroups are sensitive to loss
of both the regulatory and catalytic activities of mRNA decapping and argue that they are indirectly
controlled by the status of general decapping activity in yeast cells.
Unlike the transcripts targeted directly by Pat1, Lsm1, and Dhh1, transcripts controlled indirectly
by these factors are translated efficiently. Transcripts from the Down-o-d and Down-a-pld subgroups
generally have higher average codon optimality scores, lower ribosomal occupancy, and higher pro-
tein production (Figure 7). These observations suggest that the susceptibility of these transcripts to
the loss of Pat1, Lsm1, and Dhh1 functions is likely to be dictated by their unique properties in trans-
lation. The Down-o-d subgroup contains a small set of NMD substrates (Figure 8C) and the
decreased accumulation of these NMD-regulated transcripts in dhh1D cells largely results from more
efficient decapping by an NMD-dependent mechanism (Figure 8D, right panel). Because Dhh1
forms several distinct complexes with the decapping enzyme (Sharif et al., 2013; Fromm et al.,
2012; Tritschler et al., 2009), more efficient decapping of NMD substrates in the absence of Dhh1
is likely caused by increases in the free pool of the decapping enzyme available for NMD as a conse-
quence of DHH1 deletion. The majority of transcripts controlled indirectly by Pat1, Lsm1, and Dhh1
are not typical decapping substrates (Figures 4 and 5). The decreased accumulation of these tran-
scripts in the absence of Pat1, Lsm1, and Dhh1 probably results from more efficient 3’ to 5’ degrada-
tion. One possibility is that these transcripts are normally protected by an unknown factor at their 3’-
ends. Inactivation of Pat1, Lsm1, and Dhh1 leads to the stabilization of a significant number of tran-
scripts. The stabilized transcripts might sequester the unknown factor from their normal binding sub-
strates and make the latter susceptible to 3’ to 5’ decay. An interesting implication of these
observations is that deletion of the genes encoding regulators of other steps in the gene expression
pathway may lead to similar indirect and opportunistic effects.
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Reassessing the major functions of decapping activators
Current models of mRNA decapping propose two major temporally separated functions for decapp-
ing activators, an initial repression of mRNA translation followed by stimulation of the activity of the
decapping enzyme (Parker, 2012; Nissan et al., 2010; Coller and Parker, 2005). Thus, for example,
Dhh1 is thought to function principally in repressing translation, Edc3 is thought to activate the
decapping enzyme, and Pat1 is thought to possess both activities (Nissan et al., 2010; Coller and
Parker, 2005). It is also generally believed that decapping of individual mRNAs requires the func-
tions of multiple decapping activators (Nissan et al., 2010; Coller and Parker, 2005). Our results
from in vivo expression profiling experiments presented here, and genetic analyses published earlier
(He and Jacobson, 2015a), challenge these views with data indicating that: a) the main function of
decapping activators is to provide substrate specificity, that is to target the decapping enzyme to
specific mRNAs; b) individual decapping activators target highly specific subsets of yeast transcripts
and generally do not have overlapping regulatory activities (Figure 8A); and c) the decapping
enzyme is subject to negative regulation and its activation is most likely coupled to substrate recog-
nition. These principles are not dependent on translational repression, and accumulating experimen-
tal evidence indicates that prior translational repression may not be required for decapping to
occur. Decapping of individual mRNAs occurs while they are still engaged in translation (Hu et al.,
2010; Hu et al., 2009) and this co-translational decay appears to be widespread, both in genome-
wide analyses (Pelechano et al., 2015) and in our experiments evaluating the transcripts targeted
by Dhh1 (Figure 4G). Thus, decapping activators may not have primary roles in regulating mRNA
translation, but instead may function by monitoring mRNA translation initiation, elongation, or termi-
nation to target unique features of individual mRNAs.
Materials and methods
Key resources table
Reagent type
(species)
or resource Designation
Source or
reference Identifiers Additional information
Chemical
compound,
drug
[a-32P]-dCTP Perkin Elmer Blu513Z
Chemical
compound,
drug
Herring
Sperm DNA
Promega D1815
Peptide,
recombinant
protein
Taq DNA
polymerase
Roche 04-728-874-001
Peptide,
recombinant
protein
Baseline-
ZERO DNase
Epicentre DB0711K
Peptide,
recombinant
protein
SuperScript II
Reverse Transcriptase
Invitrogen 18064–022
Strain, strain
background
(W303 or BY4741)
Yeast strains
used in this study
This paper Supplementary File 1 Contains all
yeast strains
obtained or
constructed in
this study
Recombinant
DNA reagent
Plasmids
used in this study
This paper Supplementary File 2 Contain all plasmids
constructed in
this study
Sequence-
based reagent
Oligonucleotides
used in this study
This paper Supplementary File 3 Contains all
oligonucleotides used
in this study
Antibody Mouse anti-HA
monoclonal
antibody
Sigma H3663 one to 4000
Continued on next page
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Continued
Reagent type
(species)
or resource Designation
Source or
reference Identifiers Additional information
Antibody Rabbit anti-
TAP Tag polyclonal
antibody
Thermo Fisher CAB1001 one to 1000
Antibody Mouse anti-
Pgk1 monoclonal
antibody
Invitrogen 459250 one to 8000
Commercial
assay or kit
Ribo-Zero
Gold rRNA Removal
Kit (Yeast)
Illumina MRZY1306
Commercial
assay or kit
TruSeq Stranded
mRNA LT Sample
Prep Kit
Illumina RS-122–2101
Commercial
assay or kit
Agencourt RNA
Clean XP Kit
Beckman-
Coulter Genomics
A63987
Commercial
assay or kit
Random Primed
DNA labeling Kit
Roche 11-004-760-001
Software,
algorithm
RSEM Li and Dewey, 2011 http://deweylab.
biostat.wisc.
edu/rsem
Software,
algorithm
DESeq Anders and Huber, 2010 https://bioconductor.
org/packages/release/
bioc/html/DESeq2.html
Other (Deposited
Data)
R64-2-1 S288C
sacCer3
genome assembly
Saccharomyces
Genome Database
(SGD)
https://downloads.
yeastgenome.org/
sequence/S288C_
reference/genome_
releases/
Other (Deposited
Data)
Raw and analyzed
data
This paper GEO: GSE107841 Contains raw
and analyzed
RNA-seq data
Other (Deposited
Data)
Ribosomal
profiling data
Young et al., 2015 GEO: GSE69414
Other (Deposited
Data)
Codon protection
index data
Pelechano
et al., 2015
GEO: GSE63120
Other (Deposited
Data)
Normalized yeast
codon optimality
scores
Pechmann and
Frydman, 2013
http://www.stanford.
edu/group/frydman/codons
Other (Deposited
Data)
Scaled estimates
of yeast proteomic
data
Wang et al., 2012 http://pax-db.org/
Yeast strains and plasmids
Yeast strains used in this study are in the W303 or BY4741 backgrounds and are listed in
Supplementary File 1. The wild-type strain (HFY114) and its isogenic derivatives harboring deletions
of UPF1 (HFY871), DCP1 (HFY1067), or XRN1 (HFY1080) were described previously (He et al.,
2003), as were isogenic strains harboring deletions of DCP2 (CFY1016), EDC3 (CFY25), PAT1
(SYY2674), LSM1 (SYY2680), or DHH1 (SYY2686), or the dcp2-N245 truncation of the Dcp2 C-termi-
nal domain (SYY2385) and alleles thereof (He and Jacobson, 2015a). Isogenic strains harboring the
C-terminally truncated, catalytically deficient dcp2-E153Q-N245 (SYY2750) and dcp2-E198Q-N245
(SYY2755) alleles or deletions of SCD6 (SSY2352), SKI2 (HFY1170), SKI7 (SYY17), or both SKI2 and
SKI7 (SYY21) were constructed by gene replacement (Guthrie and Fink, 1991) using DNA fragments
harboring dcp2-E153Q-N245::KanMX6, dcp2-E198Q-N245::KanMX6, scd6::KanMX6, ski2::URA3,
ski7::URA3, or ski2::URA3 and ski7::ADE2 null alleles, respectively. Double mutant strains dcp2-N245
xrn1D (SYY2887), dcp2-E153Q-N245 xrn1D (SYY2897), and dcp2-E198Q-N245 xrn1D (SYY2901) were
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constructed by gene replacement using DNA fragments harboring the xrn1::ADE2 null allele. Double
mutant strains dcp2-N245 ski2D (SYY2889), dcp2-N245 ski7D (SYY2893) and upf1D dhh1D (SYY2700)
were constructed by gene replacement using DNA fragments harboring ski2::URA3, ski7::URA3, and
dhh1::ADE2 null alleles, respectively. The use of temperature-sensitive rpb1-1 cells to measure
mRNA decay rates in yeast has been described previously (Herrick et al., 1990; Dong et al., 2007).
Isogenic rpb1-1 strains harboring deletions of PAT1 (SYY2959), LSM1 (SYY2965), and DHH1
(SYY2971) were constructed by gene replacement using DNA fragments harboring pat1::URA3,
lsm1::URA3, and dhh1::URA3 null alleles, respectively. Genomic TAP-tagged PAT1, LSM1, and
DHH1 strains were obtained from Dharmacon, and isogenic TAP-tagged strains harboring deletions
of PAT1 (SYY2944 and SYY2950), LSM1 (SYY2938 and SYY2953), and DHH1 (SYY2941 and SYY2947)
were constructed by gene replacement using DNA fragments harboring pat1::URA3, lsm1::URA3,
and dhh1::URA3 null alleles, respectively.
Yeast strains used for our RNA-Seq experiments have mostly been characterized in a previous
study (He and Jacobson, 2015a). Doubling times of these strains in standard YEPD media at 30˚C
were: wild-type strain (HFY114), 1.5 hr; dcp2-N245 strain (SYY2385), 1.8 hr; dcp2-E153Q-N245 strain
(SYY2750), 5.0 hr; dcp2-E198Q-N245 strain (SYY2755), 3.6 hr; pat1D strain (SYY2674), 2.7 hr; lsm1D
strain (SYY2680), 3.0 hr; and dhh1D strain (SYY2686), 2.3 hr.
Plasmids harboring the knock-in or knock-out alleles used in this study are described in
Supplementary File 2.
Cell growth and RNA isolation
Cells were all grown in YEPD media at 30˚C. In each case, cells (15 ml) were grown to an OD600 of
0.7 and harvested by centrifugation. Cell pellets were frozen on dry ice and then stored at  80˚C
until RNA isolation. Procedures for total RNA isolation and the measurement of mRNA decay rates
using temperature-sensitive rpb1-1 cells were as previously described (He and Jacobson, 1995).
Analysis of protein levels
Preparation of whole-cell extracts and western blotting procedures were as described previously
(Dong et al., 2007). Western blots were probed with specific antibodies, including a mouse mono-
clonal antibody targeting the HA epitope (H3663, Sigma), rabbit polyclonal antibodies recognizing
the TAP Tag (CAB1001, Thermo Fisher), and a mouse monoclonal antibody against Pgk1 (459250,
Invitrogen). The latter polypeptide served as a loading control. Proteins were detected using ECL
reagents (GE Healthcare) and Kodak BioMax film.
RNA-Seq library preparation and sequencing
Procedures for RNA-Seq library construction were as previously described (Celik et al., 2017). In
brief, total RNA was treated with Baseline-zero DNase (Epicenter) to remove any genomic DNA con-
tamination. Five micrograms of DNase-treated total RNA was then depleted of rRNAs using the Illu-
mina yeast RiboZero Removal Kit and the resulting RNA was used for RNA-Seq library preparation.
Multiplex strand-specific cDNA libraries were constructed using the Illumina TruSeq Stranded mRNA
LT Sample Prep Kit. Three independent cDNA libraries were prepared for each yeast strain analyzed.
Total RNA cDNA libraries were sequenced on the Illumina HiSeq4000 platform at Beijing Genomics
Institute. Four independent libraries were pooled into a single lane and single-end 50-cycle sequenc-
ing was carried out for all cDNA libraries.
Northern analysis
Procedures for northern blotting were as previously described (He and Jacobson, 1995). In each
case, the blot was hybridized to a random primed probe for a specific transcript, with SCR1 RNA
serving as a loading control. Transcript-specific signals on northern blots were determined with a
FUJI BAS-2500 analyzer. DNA fragments from the coding regions of specific genes were amplified
by PCR using the oligonucleotides listed in Supplementary File 3 and these DNA fragments were
used as probes for the northern analyses. Probes generated for these analyses included CIT2 nt 1–
500, SDS23 nt 1–500, HOS2 nt 1–500, PYK1 nt 1–500, DIF1 nt 1–400, AGA1 nt 1–500, BUR6 nt 1–
429, LSM3 nt 1–270, HXT6 nt 1–470, GPH1 nt 1–500, HXK1 nt 60–480, CHA1 nt 1–500, RTC3 nt 1–
336, NQM1 nt 481–1002, PGM2 nt 1201–1710, TMA10 nt 1–260, GAD1 nt 1–480, SPG4 nt 1–340,
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MUP3 nt 1–500, GTT2 nt 1–500, RPP1A nt 1–321, TMA19 nt 1–500, GPP2 nt 1–500, YIL164C nt 201–
600, THI22 nt 1207–1700, EST1 nt 1621–2094, TRP1 nt 1–675, ALR2 nt 1–500, GDH1 nt 766–1365,
ARL1 nt 1–552, DAL3 nt 1–588, YGL117W nt 95–691, RPS9A nt 599–1095, SUC2 nt 1001–1599,
CPA1 nt 668–1236, HIS4 nt 97–2328, SER3 nt 811–1410, HAC1 nt 662–913 and HSP82 nt 1544–
2130.
Bioinformatic methods
General computational methods
All statistical analyses were carried out using the R statistical programming environment, versions
3.3.2 and 3.3.4. R packages ggplot2, gplots, plyr, reshape2, and gridExtra were used for data pre-
processing and visualization. Biostrings, BiocParallel, doSnow, and doParallel were used for parallel
processing. Statistical tests were performed using built-in functions in base R distributions. Hierarchi-
cal clustering was performed using Euclidian distances between libraries and transcripts with com-
plete linkage. Non-finite (division by 0) and undefined (0 divided by 0) values were removed prior to
clustering. The heights of the clustering tree branches indicate distance between two libraries. We
used Fisher’s exact test to assess different subsets of transcripts for either enrichment or depletion
of a particular group of transcripts. We used external data (codon protection index, codon optimal-
ity, and protein abundance) as presented by the respective authors without any further refinement.
Transcripts that were not included in these datasets were discarded prior to statistical testing.
Analysis of differential mRNA expression
Transcripts differentially expressed in each of the mutant strains relative to the corresponding wild-
type strain were identified using bioinformatics pipelines described previously (Celik et al., 2017). In
brief, the Saccharomyces cerevisiae R64-2-1 S288C reference genome assembly (sacCer3) was used
to construct a yeast transcriptome comprised of 7473 transcripts. This transcriptome includes all
annotated protein-coding sequences, functional and non-coding RNAs, and the unspliced isoforms
of all intron-containing genes, but excludes all of the autonomous replicating sequences and long
terminal repeats of transposable elements. The RSEM program (Li and Dewey, 2011) was used to
map sequence reads to the transcriptome and to quantify the levels of individual mRNAs with set-
tings –bowtie-m 30 –no-bam-output –forward-prob 0. The expected read counts for individual
mRNAs from RSEM were considered as the number of reads mapped to each transcript and were
then imported into the Bioconductor DESeq package (Anders and Huber, 2010) for differential
expression analysis. The Benjamini-Hochberg procedure was used for multiple testing corrections.
To account for replicate variability, we used a false discovery threshold of 0.01 (1%) instead of an
arbitrary fold change cutoff as the criterion for differential expression.
Analysis of potential mechanisms of mRNA decay
Our expression analysis identified the transcripts regulated by Pat1, Lsm1, and Dhh1. To assess the
potential decay mechanisms for the respective sets of transcripts, we analyzed the expression pat-
terns of these mRNAs in mutant cells deficient in decapping or 5’ to 3’ exoribonuclease activities. In
addition, to assess the degree of co-translational decay, we also analyzed the codon protection indi-
ces (Pelechano et al., 2015) of these mRNAs in wild-type yeast cells under normal growth coditions.
In our analyses, transcripts regulated by Pat1, Lsm1, and Dhh1 could be divided into six different
subgroups. The up-regulated transcripts were grouped into Up-o-d, Up-o-pl, and Up-a-pld and the
down-regulated transcripts were grouped into Down-o-d, Down-o-pl, and Down-a-pld subgroups
(see Results). Boxplots were used to examine the distribution and the median value of both the rela-
tive levels and the codon protection indices for transcripts from each of these six subgroups. The rel-
ative levels of individual mRNAs in mutant cells were determined by comparison to their levels in
wild-type cells. The expression data for dcp1D, dcp2D, and xrn1D cells were from our previously pub-
lished work (Celik et al., 2017). Codon protection indices for individual mRNAs were generated by
Pelechano and collegues based on their data from 5’P sequencing of yeast decay intermediates
(Pelechano et al., 2015). In their study, the codon protection index of a specific transcript is defined
as the ratio of sequencing reads in the ribosome protected frame over the average reads of the
non-protected frames. Codon protection index values greater than one are indicative of co-transla-
tional decay.
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Analysis of intrinsic properties associated with mRNA translation
To assess the potential links between translation and the functions of Pat1, Lsm1, and Dhh1 in
mRNA decay, we examined several intrinsic properties associated with mRNA translation for tran-
scripts regulated by these three factors. We analyzed the pattern and distribution of the average
codon optimality score, the average ribosome density, and the estimated protein abundance for
transcripts from the six subgroups of mRNAs controlled by Pat1, Lsm1, and Dhh1. In our analysis,
the average codon optimality score of individual mRNAs was calculated based on the optimal or
non-optimal codon scores defined by Pechmann and Frydman (Pechmann and Frydman, 2013). The
average ribosome density of individual mRNAs was derived from published ribosome profiling and
RNA-Seq data from wild-type yeast cells grown under standard conditions (Young et al., 2015) and
was calculated as previously described (Celik et al., 2017). In brief, raw fastq files were downloaded
and sequence reads were trimmed for adapter sequences using cutadapt with settings -a
CTGTAGGCA -q 10 –trim-n -m 10. After adapter trimming, sequence reads were mapped to the
transcriptome using bowtie (Langmead et al., 2009) with settings -m4-n2l15 –suppress 1,6,7,8 –best
–strata. After bowtie alignment, the riboSeqR (He and Jacobson, 2015b) was used for preliminary
visualizations and frame calling. For our ribosome occupancy calculations, we selected read lenghts
that showed a strong preference (> 80%) to a specific reading frame. After this filtering, the ribo-
some occupancy of individual mRNAs was calculated as coverage_ribo/coverage_rna, yielding a sin-
gle value of ribosome occupancy for each mRNAs. We used these values to compare the translation
efficiency of transcripts from different subgroups of mRNAs that are differentially expressed in
pat1D, lsm1D, and dhh1D strains. We excluded transcripts that had no RNA-Seq reads mapping to
their ORFs in our analysis. Protein abundance levels came directly from the curated PaxDb (Protein
Abundances Across Organisms) database (Wang et al., 2012) and are the scaled aggregated esti-
mates over several proteomic data sets.
Deposited Data
The data discussed in this publication have been deposited in NCBI’s Gene Expression Omnibus and
are accessible through GEO Series accession number GSE107841 at the link https://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE107841.
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